Development of a Cabozantinib (Cabometyx) Symptom Management Application for Use in Patients With Renal Cancer
Clinical trial NCT03867045 · TERMINATED
Trial details
- NCT number
- NCT03867045
- Sponsor
- Duke University
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-21
- Primary completion
- 2019-12-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.